Researchers at Rush University Medical Center and the MIND Institute at UC Davis have found that mavoglurant, an experimental drug known as an mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome.
News & Events
The Rush System is expanding its network of outpatient care centers with a new, 40,000-square-foot location in Chicago’s South Loop.
Rush and the Angelman Syndrome Foundation announced the official opening of the Angelman Syndrome Clinic at Rush University Children’s Hospital, the first in Illinois and one of only eight in the U.S.
Dr. Kyran Quinlan and colleagues at Rush issue an urgent call for prevention strategies for sleep-related infant deaths in his viewpoint, “Protecting Infants From Sleep-Related Deaths” published in the June 18 online issue of JAMA Pediatrics.
Cardiac specialists at Rush University Medical Center are among the doctors highlighted as “Chicago’s Top Cardiologists,” in a special edition of Chicago magazine’s “Top Doctor’s” list included in the magazine’s June 2018 issue.